Photochemical activation of drugs for the treatment of therapy-resistant cancers (Q38409528)

2 September 2017

1 reference

title

Photochemical activation of drugs for the treatment of therapy-resistant cancers (English)

1 reference

2 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25849953%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Pål Kristian Selbo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25849953%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

6

Kristian Berg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25849953%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Maria E B Berstad

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25849953%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Bente Bull-Hansen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25849953%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Cathrine E Olsen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25849953%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

7 April 2015

1 reference

Photochemical and Photobiological Sciences

2 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25849953%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25849953%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25849953%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

1465-1475

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25849953%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms of acquired resistance to targeted cancer therapies.

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Mechanism-based cancer therapy: resistance to therapy, therapy for resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Drug resistance in cancer: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Cancer drug resistance: an evolving paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Mechanisms and strategies to overcome multiple drug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

An epigenetic mechanism for capecitabine resistance in mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Multiple drug resistance mechanisms in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Mechanisms and novel approaches in overriding tyrosine kinase inhibitor resistance in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Mechanisms and implications of imatinib resistance mutations in BCR-ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Considerations for early switch to nilotinib or dasatinib in patients with chronic myeloid leukemia with inadequate response to first-line imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Disulfonated tetraphenyl chlorin (TPCS2a), a novel photosensitizer developed for clinical utilization of photochemical internalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Photodynamic therapy of cancer: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Photochemical internalization of bleomycin is superior to photodynamic therapy due to the therapeutic effect in the tumor periphery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Photosensitisation facilitates cross-priming of adjuvant-free protein vaccines and stimulation of tumour-suppressing CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Intradermal photosensitisation facilitates stimulation of MHC class-I restricted CD8 T-cell responses of co-administered antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Photodynamic therapy: superficial and interstitial illumination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Site-specific drug delivery by photochemical internalization enhances the antitumor effect of bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Photodynamic therapy of malignant brain tumours: a complementary approach to conventional therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Photochemical internalization as an adjunct to marginal surgery in a human sarcoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Design and development of polymers for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Recent advances with liposomes as pharmaceutical carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Enhancement of immunotoxin activity using chemical and biological reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Saponins as tool for improved targeted tumor therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

How does P-glycoprotein recognize its substrates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Pathways of clathrin-independent endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Photochemical internalization of therapeutic macromolecular agents: a novel strategy to kill multidrug-resistant cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Circumvention of resistance to photodynamic therapy in doxorubicin-resistant sarcoma by photochemical internalization of gelonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Resistance mechanisms associated with altered intracellular distribution of anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Defective acidification in human breast tumor cells and implications for chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Reversal of doxorubicin resistance in breast cancer cells by photochemical internalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Role of the Glutathione Redox Cycle in Acquired and de Novo Multidrug Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Association of reactive oxygen species levels and radioresistance in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Nuclear trafficking of the epidermal growth factor receptor family membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Nuclear EGFR contributes to acquired resistance to cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Photochemical disruption of endocytic vesicles before delivery of drugs: a new strategy for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Photochemical activation of the recombinant HER2-targeted fusion toxin MH3-B1/rGel; Impact of HER2 expression on treatment outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Photochemical internalization (PCI) of immunotoxins targeting CD133 is specific and highly potent at femtomolar levels in cells with cancer stem cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Light-triggered, efficient cytosolic release of IM7-saporin targeting the putative cancer stem cell marker CD44 by photochemical internalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Photochemical internalization augments tumor vascular cytotoxicity and specificity of VEGF(121)/rGel fusion toxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Antibody-drug conjugates: an emerging modality for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Brentuximab vedotin for treating Hodgkin's lymphoma: an analysis of pharmacology and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Antibody-drug conjugates in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G

Ribosome-inactivating proteins from plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5PP00029G